The Food and Drug Administration's Center for Devices and Radiological Health (CDRH) has presented a picture of remarkable operational stability in its 2025 annual report, successfully maintaining its core device review functions despite navigating significant internal pressures and substantial
The medical technology landscape witnessed an unprecedented wave of consolidation and strategic realignment in 2025, with merger and acquisition activity skyrocketing to approximately $80 billion by the end of November. This remarkable figure, which eclipsed the combined deal values of the
A major infusion of capital from a global medical technology leader is set to reshape the industrial landscape of central Mexico, signaling a pivotal moment in the nation's push to become a high-tech manufacturing powerhouse. Abbott, a company with deep historical roots in the region, has committed
For decades, a diagnosis requiring specialized medical intervention in Kashmir has often been accompanied by the daunting prospect of a long and arduous journey to metropolitan centers like Delhi, a reality that has imposed immense financial and emotional burdens on countless families. This exodus
The increasingly interconnected landscape of modern healthcare technology presents a profound challenge for innovators, demanding a delicate balance between rapid development and unwavering adherence to stringent safety and regulatory standards. CLEIO, a prominent ISO 13485–certified product
A recent clarification from the U.S. Food and Drug Administration has drawn a much-needed line in the sand for the burgeoning wearable technology industry, specifically distinguishing between general wellness devices and regulated medical equipment. This newly defined regulatory landscape has
